Uduagbamen Peter Kehinde, Bamikefa Titilope Adetoun, Shitu Abdul-Karim Olayinka, Omokore Olutomiwa Ayoola, Nwachukwu Nwachukwu Olusegun, Alo Demilade Jolaoluwa
Division of Nephrology and Hypertension, Department of Internal Medicine, Bowen University, Iwo /Bowen University Teaching Hospital, Ogbomosho, Nigeria.
Division of Nephrology and Hypertension, Department of Internal Medicine, Ben Carson (Snr) School of Medicine, Babcock University/ Babcock University Teaching Hospital, Ilishan-Remo, Nigeria.
Niger Med J. 2025 Jan 10;65(6):925-933. doi: 10.60787/nmj.v65i6.532. eCollection 2024 Nov-Dec.
Dialysis vintage is largely dependent on the effectiveness of the delivered dose coupled with the extent of patient compliance with the prescribed treatment regimen. This study assessed the determinants and correlates of dialysis vintage. : This was a 4-year prospective, observational study. The data was collected from the dialysis and medical records, both had the contacts of patients and relatives.
A total of 314 participants (males 67.20%) with a mean age of 47.91±8.81 years underwent 2265 maintenance haemodialysis sessions. The females were older and had more hospital admissions; (P=0.07). Approximately 32.17% of the participants traveled at least fifty kilometers to access dialysis treatment In a month, only 23.57% of the participants received the minimum prescribed twelve sessions, and 24.84% received the required erythropoietin dose. The mean dialysis vintage for all population was 9.13 ± 3.15 months, it was shorter for participants with hospitalization, (p<0.001), dialysis termination (p<0.001), intradialytic hypotension (p<0.001), and hypertension (p<0.001), Approximately, 14.2% of the participants had health insurance coverage, more so with the men After dialysis initiation, 6.69% of the participants were alive to the fourth year. The predictors of dialysis vintage were income (OR-4.62, 95% CI-2.88-6.24), health insurance (OR-8.11, 95% CI-4.82-13.35), dialysis duration (OR-6.38, 95% CI-2.40-9.55) and spKt/V (OR-4.24, 95% CI-0.48-5.91).
Dialysis vintage was short (9.13 ± 3.15 months), more so in females, poor funding, peridialysis complications, and without health insurance. More concerted efforts from governments, multinational donor agencies, and philanthropists are needed in health insurance coverage, particularly for kidney care to increase the dialysis vintage.
透析龄在很大程度上取决于所给予剂量的有效性以及患者对规定治疗方案的依从程度。本研究评估了透析龄的决定因素及相关因素。这是一项为期4年的前瞻性观察性研究。数据收集自透析记录和医疗记录，二者均包含患者及其亲属的联系方式。
共有314名参与者（男性占67.20%），平均年龄为47.91±8.81岁，接受了2265次维持性血液透析治疗。女性年龄更大，住院次数更多；（P=0.07）。约32.17%的参与者每月前往至少50公里外的地方接受透析治疗。一个月内，只有23.57%的参与者接受了规定的最少12次治疗，24.84%的参与者接受了所需的促红细胞生成素剂量。所有人群的平均透析龄为9.13±3.15个月，住院患者（p<0.001）、透析终止患者（p<0.001）、透析中低血压患者（p<0.001）和高血压患者（p<0.001）的透析龄较短。约14.2%的参与者有医疗保险，男性更多。透析开始后，6.69%的参与者存活至第四年。透析龄的预测因素包括收入（OR-4.62，95%CI-2.88-6.24）、医疗保险（OR-8.11，95%CI-4.82-13.35）、透析时长（OR-6.38，95%CI-2.40-9.55）和spKt/V（OR-4.24，95%CI-0.48-5.91）。
透析龄较短（9.13±3.15个月），女性更甚，资金不足、透析并发症以及没有医疗保险都是导致透析龄短的原因。政府、跨国捐赠机构和慈善家需要在医疗保险覆盖方面做出更协调一致的努力，特别是在肾脏护理方面，以提高透析龄。
